Medical Device, Biotech & Healthcare Business Plans

Our experience in life sciences spans the following areas:

Medical Device, Biotech & Healthcare Industry Consultants

Our team of life science, biotech, medical device, and healthcare specialists includes the following consultants:

  Jenifer Grant, MBA - Principal Consultant

Jenifer has been involved with finance, strategy, and marketing in a wide variety of roles and industries for over 15 years. In addition to third-party clients, she developed plans and implemented strategies for internal new businesses within IT and investment banking during the corporate phase of her career. Jenifer's clients range from start-up through high middle market companies in fields including IT, software, green tech / renewable energy, telecom services, wireless, financial services, Internet/e-commerce, media/entertainment, healthcare products and wellness, consumer and industrial products, retail, mining and commodities, energy and tourism.

Prior to working as an independent consultant, Jenifer structured and managed transactions in global merchant banking and derivatives, and held strategic planning and management positions within investment banking and IT functions at Bankers Trust Company. Earlier, she worked in credit corporate finance at Manufacturers Hanover and portfolio strategy, equity and fixed income research at Kidder Peabody.

Jenifer has an MBA in Finance from Wharton and a BA in Economics from Columbia.

  Richard Hasenpflug, MBA - Principal Consultant

Richard has been bringing Fortune 100 expertise to startups and small to mid-sized businesses since 1985. He is both a consultant and serial entrepreneur and has participated in several startup teams either as CEO or CFO. After an extensive career in Silicon Valley, he relocated to Arizona in 2008.

Richard has worked with clients spanning a variety of industries, both domestically and overseas, including healthcare, high-tech market research, international trade, multinational operations & marketing, offshoring, publishing, semiconductor equipment, supply-chain management, and telecommunications.

Richard's focus internationally has been on building strong multi-national teams and bringing the lessons learned in Silicon Valley to other industries and countries. He was active in Russia during the 1990s, working with privatized state-owned companies and supporting local startups and multinational joint ventures. He also led the creation of a worldwide trading network focused primarily in Europe.

Prior to 1985, Richard held a variety of management, development, finance and marketing positions in international and high-tech companies. Based in Singapore, he was Director of Finance and Corporate Credit for Monsanto Corporation's Asian operations for several years, establishing corporate risk levels throughout the region and actively working with and supporting customers. Richard has served as an officer and/or director of several industry associations and non-profit organizations. He was named Los Altan of the Year in 2002 for his many years of work in support of local education, worldwide AIDS education, and international understanding.

Richard earned an MBA in International Management from the Thunderbird School of Global Management, a BA in History from The Ohio State University, and graduated from the Marketing Management Executive Program at Columbia University's Graduate School of Business.

  David Kaplan, JD - Principal Consultant

David has written investment grade business plans, consulted in strategic planning and facilitated management strategy meetings for operating companies since 1994. He has advised scores of scientists, researchers, inventors and business innovators in turning nascent ideas into concrete, executable business plans. Client engagements have included biotechnology and early stage drug development, consumer products and services, software, healthcare, medical devices, Internet, high tech, fish farming, automotive products and services, elder care, publishing and others.

Earlier, David founded several successful startups. His first was DSK Cars in Marblehead Mass, where he manufactured sports/racing cars of his own design by hand from raw materials. He also founded PoleStar LLC, a consultancy to entrepreneurs; Your Auto Expert, an alternative Internet based car retailer and; Purgatory Cove Press, the publisher of four fishing guide books he wrote about Middlesex County Massachusetts. David served as an affiliate at the Boston University Healthcare Entrepreneurship Program and taught Entrepreneurial Management at B.U.

David consulted to the world-wide auto industry at Temple, Barker and Sloan; served as General Counsel and Director of Marketing at Callaway Engineering; and litigated on behalf of Native Americans in state and federal courts.

David earned a Phi Beta Kappa and BA Magna cum Laude at Amherst College and a JD with honors from Harvard Law School.

  Malcolm McLelland, Ph.D. - Principal Consultant

Malcolm has over 24 years' experience in financial modeling and econometric analysis gained in public accounting, commercial lending, and academic institutions. He has been engaged in such matters by firms in the manufacturing, processing, technology, real estate, and financial services industries, as well as by financial institutions and their regulatory agencies. His financial models have been used in financial planning and performance measurement, development of corporate governance and management control systems, merger and acquisition analysis and structuring, negotiating private debt and equity placements, capital (re)structuring and reorganization, business valuation, and commercial damages litigation consulting.

Malcolm's academic research focuses on how accounting information is used in equity markets, how managers make optimal financial reporting decisions, and how professional labor markets in accounting, finance, and information systems work. His research has been published in Review of Accounting & Finance and Managerial Finance, and he has written a number of monographs and articles included in professional publications and periodicals. Malcolm has taught a wide range of courses including financial accounting and analysis, managerial accounting and decision-making, corporate governance, asset pricing theory and business valuation at Michigan State University, University of Illinois at Chicago, Purdue University, and most recently at Indiana University.

Malcolm was graduated from Indiana University with a B.S. in 1981, and from Michigan State University with a Ph.D. in 1999.

  Principal Consultant, MBA

Our San Francisco consultant has over twenty years of experience as a management consultant. He specializes in working with San Francisco Bay Area / Silicon Valley companies seeking venture capital. He is the author of numerous business plans leading to successful multi-million dollar investments. His plans have been used to raise capital, to solve critical business problems, and to persuade investors, boards, and senior management to take action. His plans are effective because they are based upon thorough qualitative and quantitative analysis, yet are able to communicate complex ideas in a simple straightforward manner.

He has client experience in high tech, green tech / alternative energy, commercial real estate, construction materials, financial services, biotech, aerospace, manufacturing, hospitality, and service industries.

He earned his MBA from Harvard University and his BA in Biochemistry from Brown University.

  Hal Siegel, Ph.D. - Senior Advisor

Dr Siegel has over 20 years experience across R&D and regulatory affairs, and supported multiple VC and public fundraising rounds, founding Siegel Consultancy LLC in 2001. For the past 8 years, Siegel served ImmuneRegen (as Senior VP, Product Development and Regulatory Affairs, and then VP and CSO), then Zila, Inc. (as VP, responsible for the company’s Phase 3 oncology program and device activities, as FDA liaison and establishing multiple research collaborations).

From 2000-2003, Siegel served in the FDA-regulated information technology space, in Sun Microsystems Life Sciences Group, and BioQ, integrating regulatory and scientific content into a SaaS product (a collaboration with IBM, Accenture and Autonomy).

Siegel spent 1993-1998 at Advanced Bioresearch Associates, a boutique CRO, providing regulatory, clinical and scientific support, including to a botanical drug startup acquired by Wyeth-Ayerst. He joined ABA following positions at Hybritech Inc. (an Eli Lilly company) and Iatric Corporation, where he was responsible for regulatory and compliance activities for biological products and a monoclonal antibody/drug product.

He obtained his B.S. Biology from RPI, his PhD in Biochemical Pharmacology from SUNY Buffalo and performed post-doctoral research at Los Alamos National Laboratory and at the Barrow Neurological Institute. He serves on the Phoenix Leadership group of AZBio, the Arizona life science industry trade group.

Medical Device, Biotech & Healthcare Industry Experience

Our experience in the life sciences, either as consultants, entrepreneurs, or employees in the industry, includes the following:

• Artificial Heart Technologies: Developed the business plan, financial forecast, and website for SynCardia Systems, a medical device company. SynCardia develops, manufactures, and markets the CardioWest Total Artificial Heart systems for use as a bridge to transplant in patients with end-stage heart failure. "The materials that Cayenne created for us enabled us to ultimately close several large rounds of financing and reach where we are today," said Dr. Marvin Slepian, co-founder and Chairman of SynCardia.
• Biotechnology Reagents: Prepared the business plan and financial model for a large division of a billion-dollar public biotechnology company. The business makes instruments, consumables and software for scientists worldwide who are engaged in medical research; pharmaceutical drug discovery, development, and manufacturing; agriculture research; biosecurity; and quality and safety testing. "[The consultant] has done a great job and we very much enjoy working with him," remarked the division's Senior Director of Product Management.
• Heart Transplant Tissue Rejection Monitoring: Prepared the business plan, financial forecast, and investor presentation for TransWorld Med, a medical device company. TransWorld has developed an innovative technique for monitoring tissue rejection among heart transplant recipients. This technique overcomes serious problems presented by currently available techniques. The company's CEO, Dr. Charles Richardson, M.D., said: "We were amazed by how Cayenne helped us crystallize our value proposition and our competitive advantages. Their research turned up important data even we weren't aware of. And the financial forecasts blew our accountant away. We would recommend Cayenne Consulting to anybody who needs sound advice."
• Cardiology: Prepared the business plan and investor presentation for Florence Medical, a medical device company. Florence develops advanced systems based on computational flow dynamics for diagnosing and treating cardiovascular disease. "We received an outstanding business plan, and the process was fast and easy. Cayenne Consulting excels in taking complex ideas and making them understandable to non-specialists," said Frank Martin, CEO of Florence Medical.
• Rehabilitation Services: Developed the business plan and financial forecast for Safe Harbor Retreat, a developer of the first high-end substance abuse rehabilitation center on the East Coast. The company has forged alliances with several of the world's foremost experts in addiction treatment, and is in the process of securing a prime facility in the Hamptons section of Long Island. "Cayenne did a wonderful job of helping us communicate our vision to equity investors, lenders, and strategic partners," said Joe McKinsey, Founder and CEO. "The level of personal attention and service is truly remarkable."
• Brain Cancer Drug Delivery: Prepared the business plan, financial forecast, and investor presentation for CytoDome, a medical device company. CytoDome is developing a local drug delivery device that aims at regulating drug uptake by ailing brain tissue. The device is based on a novel technological approach. When asked how he would describe Cayenne Consulting to fellow entrepreneurs, Gill Heart, President and CEO of CytoDome responded: "If you need a reliable, independent, accurate, and prompt consultant to write your business plan, do not hesitate to engage Cayenne."
• Interventional Radiology: Prepared the business plan, financial forecast, and investor presentation for UltraGuide, a medical device company. The company develops advanced guidance systems for interventional radiology. "Feedback from investors has been extremely positive. We would recommend Cayenne Consulting to any early stage company seeking venture capital," said Mike Sims, CEO of UltraGuide.
• Remote Patient Monitoring: Prepared the business plan, financial forecast, and investor presentation for QRS Systems, a medical device company. The company has developed a groundbreaking implantable medical device and monitoring system that eliminates the need for endomyocardial biopsies (EMB) in heart transplant patients. Cayenne also performed prospective valuation analyses and researched acquisition multiples of comparable companies. "We were very pleased with the integrated worksheets and the ability to modify variables allowing for ease of use and clarity it brought to our financial decisions and projections," said Anthony Curlo, Director. "Cayenne is personable, professional, knowledgeable, responsive and reliable."
• Biodegradable Stent for BPH: Prepared the business plan, financial forecast, and website for Harmonia Medical Technologies, a medical device company. Harmonia develops cutting-edge, biodegradable polymer-based, local drug delivery stenting technologies for treating Benign Prostatic Hyperplasia (BPH). "I would like to thank you for an extraordinary business plan... Your promptness, focus and time management as well as cost effectiveness are excellent. Well done!", said Gill Heart, COO of Harmonia Medical Technologies. "Let me take this opportunity to thank you for the excellent job you did for Harmonia. I circulated the plan among my partners [at Veritas Venture Partners], as an example of what a b-plan should look like," said Gideon Tolkowsky, Managing Partner of Veritas Venture Partners, an investor in Harmonia.
• Neurological Pharmaceuticals: Prepared a market assessment for a pharmaceutical company seeking to understand the business potential for a promising early-stage pharmaceutical used in the treatment of neurological disorders.
• Medical Device for Wound Management: Prepared the business plan, financial forecast, and investor presentation for a medical device company that develops and markets a unique line of wound care technologies. "The new business plan explains twice as much in less than half the words than our old plan. And the flexibility, robustness, and completeness of the financial model is incredible," said the President and CEO of the company.
• Medical Diagnostic Software: Prepared the business plan and financial forecast for a developmental stage, Miami-based enterprise that was conceived to provide a convenient, confidential, and affordable way for consumers to access diagnostic laboratory results and manage their own health. The service provides a direct-to-consumer service that is similar in nature to over-the-counter tests such as home pregnancy tests that one may purchase at the corner drug store. While this service cannot be performed at home, it can be ordered without the interaction of the family physician. The client used the business plan to raise capital and to negotiate long term service agreements with diagnostic laboratories.
• Personal Emergency Response Systems: Developed a marketing plan, PPM draft, business plan, executive summary, investor presentation, and cash flow analysis for Innovate, Inc. Innovate is launching a technology and that will revolutionize personal emergency response systems. "We were thoroughly pleased with all components of this collaborative effort and would be quick to recommend their services to other entrepreneurs," said Anthony Curlo, President. "The highly polished plan has allowed us to fast track our financing, ultimately one step closer to our end game."
• Medical Records Management: Created a business plan for team of radiologists who created a HIPAA-compliant software solution that allowed the transmission and storage of radiological images by separating the image from the identifier during transmission and storage. The image and the identifier would only come together in a secure, password protected environment.
• Genomics & Proteomics: Prepared the business plan for High Throughput Genomics. HTG develops and markets advanced technologies for analyzing the transcriptome - the RNA that transcribes DNA into proteins - providing pharmaceutical companies with a tool that can revolutionize the drug discovery market. "The work that you did was quite remarkable. It's rare to find a consultant that can combine an understanding of business and science to create a persuasive and well-written business plan for a complex business like ours," said Kirk Collamer, CFO of High Throughput Genomics.
• Children's Hospital: Developed an extended executive summary for a proposed children's hospital to be developed in Nigeria. The CEO of the project remarked "The quality of the product that we have received from Cayenne is of the highest caliber and [the company] has no doubts whatsoever on the benefits of Cayenne's contributions... [The company is] delighted to leave the door open for future engagements with Cayenne."
• Physician Practice Management: Evaluated operational projects up to $2 million and acquisitions up to $20 million for an oncology physician practice management company, as the company expanded from two to thirteen states over a period of two years. Led inter-departmental due diligence and integration teams for new physician group affiliations.
• Healthcare Strategy Consulting: Managed consultant teams, market research, and day-to-day client relationships. Projects included working out a novel risk-sharing arrangement with the major regional insurance company for a 300-bed hospital and creating a managed care strategy for a rural tertiary care hospital and its affiliated physician groups.
• Laser Surgery Equipment: Served as the CTO of a start-up that developed laser-based equipment for cataract surgery. Directed early-stage research and development. Developed supporting materials for business plans, financial forecasts, and investor presentations.
• Stem Cell Bank: Consulted on a business plan and investor presentation materials for a startup stem cell bank working with leading researchers.
• SaaS Based Electronic Medical Records: Developed proprietary software architecture, business plan and investor pitch for a new concept in patient-oriented Electronic Medical Records. System was designed to overcome some of the impediments to widespread adoption of EMRs inherent in the current business model.
• Online Support Community: Prepared the business plan, financial plan, marketing plan and investor pitch for an innovative psychiatric support service which integrates online social networking tools with traditional therapy techniques.
• Cosmeceutical Hair Products: Prepared a business plan and financial model for a company focusing on addressing the hair-loss treatment segment of the hair care industry.
• Cancer Recovery Products: Developed an extended executive summary for a company that provides prosthetics and clothing, as well as grooming, styling, and therapeutic treatment products for male and female cancer survivors.
• Hospice Services: Developed a business plan for a leading hospice provider in Idaho and Eastern Oregon. As one of the only large-scale hospice providers in the region, the company is actively acquiring independently-owned hospices as well as launching services in underserved localities.
• Pharmaceuticals Distribution: Led the restructuring and privatization of Kazakhstan's national pharmaceutical distribution monopoly.
• Healthcare Consulting: Developed financial plans for a group of consulting organizations in the fields of hospital strategic planning and administration. Their activities included one of the first Electronic Medical Record systems.

Note: Some of the activities noted on these pages may reflect experience gained by a consultant prior to his or her association with Cayenne Consulting LLC. Cayenne Consulting does not offer any services that require licensing or registration with the NASD or other federal or state authorities.

I'd Like to Learn More!